In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution.
Birbeck Kevin F., Macklin Christopher P., Tiffin Nicholas J., Parsons Wendy, Dixon Michael F., Mapstone Nicholas P., Abbott Cedric R., Scott Nigel, Finan Paul J., Johnston David, Quirke Philip, Rates of Circumferential Resection Margin Involvement Vary Between Surgeons and Predict Outcomes in Rectal Cancer Surgery : , 10.1097/00000658-200204000-00001
Cristofanilli Massimo, Budd G. Thomas, Ellis Matthew J., Stopeck Alison, Matera Jeri, Miller M. Craig, Reuben James M., Doyle Gerald V., Allard W. Jeffrey, Terstappen Leon W.M.M., Hayes Daniel F., Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer, 10.1056/nejmoa040766
Eschwège P, Blanchet P, Benoit G, Jardin A, Dumas F, Le Maire V, Lacour B, Loric S, Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy, 10.1016/s0140-6736(95)92054-4
Lintula S., Vesalainen S., Rannikko A., Zhang W.‐M., Finne P., Stenman J., Stenman U.‐H., Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription‐polymerase chain reaction, 10.1080/00365510410004191
Mareel MM, Crit Rev Oncog, 4, 559 (1993)
Moreno Jose G., Miller M. Craig, Gross Steve, Allard W. Jeffrey, Gomella Leonard G., Terstappen Leon W.M.M., Circulating tumor cells predict survival in patients with metastatic prostate cancer, 10.1016/j.urology.2004.11.006
Okegawa Takatsugu, Nutahara Kikuo, Higashihara Eiji, Immunomagnetic Quantification of Circulating Tumor Cells as a Prognostic Factor of Androgen Deprivation Responsiveness in Patients With Hormone Naive Metastatic Prostate Cancer, 10.1016/j.juro.2008.06.021
Sales Jean-Patrick, Wind Philippe, Douard Richard, Cugnenc Paul-Henri, Loric Sylvain, Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer, 10.1016/s0140-6736(99)92164-5
Tombal Bertrand, Cangh Paul J. Van, Loric Sylvain, Gala Jean-Luc, Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy, 10.1002/pros.10237
Wiggers T., Jeekel J., Arends J. W., Brinkhorst A. P., Kluck H. M., Luyk C. I., Munting J. D. K., Povel J. A. C. M., Rutten A. P. M., Volovics A., Greep J. M., No-Touch isolation technique in colon cancer: A controlled prospective trial, 10.1002/bjs.1800750505
Wong IH, Clin Cancer Res, 5, 4021 (1999)
Yamashita Jun-ichi, Kurusu Yuji, Fujino Noboru, Saisyoji Tetsushi, Ogawa Michio, Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential hazard for intraoperative hematogenous tumor cell dissemination, 10.1016/s0022-5223(00)70084-5
Bibliographic reference
Eschwège, P ; Moutereau, S ; Droupy, S ; Douard, R ; Gala, Jean-Luc ; et. al. Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.. In: British journal of cancer, Vol. 100, no. 4, p. 608-10 (2009)
